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Lack of Hybridization Between Yersinia Enterocolitica 
and HLA-B27 DNA 
ANNA-MARI VIITANEN, RIITTA LAHESMAA-RANTALA, ELISABETH WEISS, and AULI TOIVANEN 
Abstract. No homology was observed between Yersinia enterocolitica 0:3 and HLA-B27 at DNA 
level when Yersinia enterocolitica chromosomal probes were hybridized with human HLA-B27 
positive leukocyte DNA or in the hybridization of Yersinia DNA with HLA-B27 specific probe. 
Our results do not exclude the existence of molecular mimicry between Yersinia proteins and 
HLA-B27 antigen, since the crossreactive epitope might be a conformational determinant not 
detected with hybridization. (J Rheumatol 1988,-15:1123-1125) 
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One popular theory to explain the pathogenetic mechanisms 
leading to reactive arthritis and other HLA-B27 associated 
diseases is the potential molecular mimicry between microbes 
and the HLA-B27 antigen12. Such a mimicry has been 
described for Shigella flexneri and Yersina enterocolitica3, 
both known as triggers of reactive arthritis, and for Kleb­
siella pneumoniae4, often connected to the etiology of 
ankylosing spondylitis (AS)5-6. Pulkkinen, et al using DNA 
hybridization and Yersinia plasmid as a probe, demonstrated 
that the potential crossreactivity of Yersinia enterocolitica 
is not mediated by the virulence plasmid7. Recently a 
sequence of 6 amino acids shared by HLA-B27 antigen and 
Klebsiella nitrogenase reductase has also been reported89. 
On this basis, our study was designed to investigate the exis­
tence of homology between Yersina enterocolitica total DNA 
and the HLA-B27 gene. 
M A T E R I A L S AND METHODS 
Experimental design. Total DNA of a strain of Yersinia enterocolitica iso­
lated from a patient with reactive arthritis was digested with the restriction 
enzyme Taql and fractionated by electrophoresis into 19 fractions. These 
were used as probes on Southern blot hybridization with total DNA from 
HLA-B27 positive and negative human leukocytes. In the reverse experi­
ments, genomic and cDNA probes cloned from the HLA-B27 gene were 
used for Yersinia enterocolitica DNA as target. 
In an additional experiment, we studied bacterial colonies isolated from 
stool samples of 11 patients with Yersinia triggered arthritis, 5 patients with 
Yersinia enteritis without arthritis and 8 controls. Strains were analyzed 
with colony hybridization technique using HLA-B27 cDNA as a probe. 
Patients. Female and male Caucasian patients with arthritis were used as 
blood donors. In addition to the clinical features the diagnosis of Yersinia 
triggered reactive arthritis was verified by the isolation of Yersinia entero-
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colitica and/or serology. HLA-B27 negative healthy persons without a history 
of yersiniosis and Yersinia antibodies were used as controls. HLA-B27 
antigen was determined by a cytotoxicity test (Histognost-B27, Behring 
Institut, Behringwerke A G , Marburg, W. Germany). 
Bacterial strains. The Yersinia enterocolitica 0:3 strain (No. 4147) used 
to prepare the probes was isolated from a patient with Yersinia triggered 
reactive arthritis and a high level of persistent IgA antibodies against he 
causative strain. The strains of Yersinia enterocolitica 0:3 used for DNA 
preparations were isolated from patients with Yersinia enteritis (No. 5432, 
4846, 2973, 3065) and from patients having reactive arthritis as a post­
infection complication (No. 2230, 6874, 4147, 1881, 5991, 2883, 5870, 
3668, 7326, 7532). Salmonella typhimurium strain (No. 5637) was isolated 
from a patient with reactive arthritis, and Shigella flexneri from a clinical 
patient. 
In an additional experiment, bacteria of normal intestinal flora were 
analyzed. Stool samples from the patients and controls were collected every 
other day during one week and 10 colonies were picked from each 
sample 1 0. The bacterial strains analyzed included E. coli, Klebsiella, Pro­
teus, Hafnia and fecal streptococci. 
Purification of Yersinia enterocolitica DNA. The strains of Yersinia entero­
colitica 0:3 were grown in brain-heart infusion (Difco, Detroit, MI) at room 
temperature overnight. Total DNA was isolated as described by Silhavy, 
et al{ 1 and digested with the restriction enzyme Taql. DNA digests were 
run on a preparative 0.7 (w/v) low gelling temperature agarose gel elec­
trophoresis for 5 h at 65 mA. The total D N A was separated into 19 frac­
tions according to the molecular weight, by cutting the gel and eluting the 
bands from the low gelling temperature agarose (Sigma, St. Louis, MO, 
U S A ) 1 2 . These fractions were employed directly as hybridization probes, 
1 μ% of D N A in each hybridization (Figure 1). Yersinia DNA digests (10 
pig) used as target were separated in agarose gel electrophoresis and trans­
ferred onto Gene Screen filters. Salmonella and Shigella strains used as 
positive controls were prepared in the same way. 
Purification of human DNA. Genomic DNA was isolated from human leuko­
cytes according to Vanderplas, et al13. DNA (10 ^g) was digested with the 
restriction enzyme Taql in the assay conditions recommended by the 
manufacturer (Amersham International, Amersham, UK), separated in an 
agarose gel electrophoresis and transferred onto a Gene Screen filter (NEN 
Research Products. Boston, M A ) . The restriction enzyme Taql was chosen 
based on the findings by Trapani, et alH, demonstrating the presence of 
a 3.5 kb Taql restriction fragment in human genomic DNA to correlate with 
the expression of HLA-B27 antigen. 
HLA-B27 derived probes, the genomic EcoRI fragment (6.7 kb) con­
taining the HLA-B27 gene and 2 overlapping cDNA fragments (1.372 and 
0.605 kb) derived from the HLA-B27 m R N A 1 5 , 1 6 , were used. 
DNA hybridization. The hybridizations were performed as described by 
Viitanen, et al: Lack of homology, Yersinia enterocolitica ά HLA-B27 
1 2 3 4 5 9 11 15 19 
Fig. 1. Southern hybridization of Yersinia enterocolitica chromosomal DNA 
(positive control) with 9 of the probes used in the present study. To pre­
pare the probes 130 μg Yersinia DNA was digested with TaqI and run in 
low gelling temperature agarose gel electrophoresis for 5 h at 65 mA. After 
electrophoresis the gel was cut in 19 pieces, DNA was isolated from the 
gel fragments, labelled by nick translation and used as probes. Numbers 
represent different probes. 
Southern17. Three washing temperatures (40, 50 and 65°C) were used when 
hybridizing Yersinia DNA with HLA-B27 probes. Colony hybridization 
filters were analyzed according to Thayer 1 8. Nick translation kit ( 3 2 P deoxy-
cytidine triphosphate (50 μ€\] in each labelling) and deoxyribonucleotide 
triphosphates (dATP, dGTP, dTTP) were used in oligonucleotide 
labelling 1 9. The HLA-B27 DNA probes were purchased from Amersham 
International (Amersham. UK). The oligonucleotide primer was produced 
by Pharmacia Biotechnology International AB (Uppsala, Sweden) and the 
Klenow enzyme by Boehringer (Mannheim, Federal Republic of Germany). 
R E S U L T S 
Genomic DNA of Yersinia enterocolitica 0:3 (strain 4147, 
derived from a patient with reactive arthritis) was fraction­
ated into 19 fractions, which were used, each separately, as 
hybridization probes on digests of human leukocyte DNA 
isolated from 3 healthy, HLA-B27 negative persons and 4 
HLA-B27 positive patients with Yersinia triggered arthritis. 
The results were negative. Total DNA of Yersinia enterocolit­
ica 0:3, Salmonella typhimurium and Shigella flexneri were 
used as positive controls. 
In the reverse experiments genomic and cDNA probes pre­
pared from the HLA-B27 gene were applied. The target DNA 
were prepared from 14 strains of Yersinia enterocolitica 0:3 
(10 strains from patients with reactive arthritis). To improve 
the sensitivity of hybridization, low washing temperatures 
were used. Even at low stringency no cross-hybridization 
signal was detected, and thus no indication for and homo­
logy between the bacterial and human DNA was observed. 
Plasmid containing HLA-B27 DNA was used as positive con­
trol of hybridization test and showed a clearly positive 
hybridization pattern. 
To find out potential DNA homology between bacteria of 
the normal intestinal flora and HLA-B27, 810 bacterial 
colonies isolated from stool samples of 11 patients with Yer­
sinia triggered arthritis, 8 patients with Yersinia enteritis 
without arthritis and 8 control persons were analyzed with 
colony hybridization technique using HLA-B27 cDNA as a 
probe. The bacterial strains were E. coli, Klebsiella, Pro­
teus, Hafnia and fecal streptococci. No evidence for homo­
logy was found in these experiments. 
DISCUSSION 
According to the molecular mimicry hypothesis, HLA-B27 
shares the antigenic activity of a microbial agent. The results 
presented here do not reveal that Yersinia enterocolitica 0:3 
chromosomal DNA codes for a sequence corresponding to 
the mRNA of HLA-B27. As no Yersinia sequences are 
present in the available (EMBL, NBRF) data banks, it was 
not possible to determine the codon usage of the Yersinia 
genome. Since the majority of polymorphic determinants are 
made of amino acids encoded by 2 triplets differing in the 
3rd position, the DNA homology should be high enough to 
be detected under the hybridization conditions employed. 
It is possible that the crossreactive epitope is a conforma­
tional determinant, which is not based on a stretch of con­
secutive amino acids and sufficient homology at the DNA 
level. In addition, the antigenic crossreactivity observed 
between HLA-B27 positive lymphocytes and microbial 
agents might be due to a small shared epitope of a few amino 
acids, which could not be discovered with common hybridi­
zation probes. In the hybridization conditions used in our 
study, the stable hybrid would not be formed between our 
relatively large probe and a very small homologous target 
DNA fragment (e.g., 20 kb) 2 0. Therefore, our findings do 
not either exclude or confirm the possible homology between 
Yersinia enterocolitica and the HLA-B27 antigen. 
The HLA-B27 probes used were isolated from a healthy 
individual1516. Whether different subtypes of HLA-B27 
have influence on the ability to trigger the disease is not quite 
clear. Mölders, et al have shown 2 types of HLA-B27 anti-
gens (K and W type) among patients with AS 2 1 . Coppin, et 
al did not find any difference between HLA-B27 antigen of 
a patient with AS and that of normal individuals22. Ness and 
Grumet23 detected 4 restriction length polymorphisms for 
the B27 gene. None of these fragments was significantly 
associated with AS and the polymorphic restriction site was 
located outside of the gene. We avoided this problem in the 
reverse experiments, when Yersinia chromosomal fragments 
J124 The Journal of Rheumatology 1988; 15:7 
were used as probes for hybridizations with human leuko-
cyte DNA as a target. 
Prendergast, et al described crossreactivity between nor-
mal intestinal flora of patients with AS and HLA-B27 anti-
gen using immunological techniques24. We analyzed 
bacterial colonies isolated from stool samples of patients with 
Yersinia triggered reactive arthritis and control persons to 
detect a homologous fragment possibly hiding in the intes-
tine, but no homology was found between normal flora bac-
teria of patients with Yersinia triggered arthritis and 
HLA-B27 DNA. Thus, it is left to sequencing studies to 
finally reveal whether a molecular mimicry between HLA-
B27 and Yersinia enterocolitica exists. 
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